Prestige Wealth Management Group’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100 | Hold |
62
| – | – | ﹤0.01% | 991 |
|
|
2025
Q1 | $76 | Hold |
62
| – | – | ﹤0.01% | 1001 |
|
|
2024
Q4 | $118 | Hold |
62
| – | – | ﹤0.01% | 1027 |
|
|
2024
Q3 | $332 | Hold |
62
| – | – | ﹤0.01% | 1000 |
|
|
2024
Q2 | $458 | Hold |
62
| – | – | ﹤0.01% | 934 |
|
|
2024
Q1 | $741 | Sell |
62
-1
| -2% | -$12 | ﹤0.01% | 905 |
|
|
2023
Q4 | $493 | Hold |
63
| – | – | ﹤0.01% | 947 |
|
|
2023
Q3 | $277 | Hold |
63
| – | – | ﹤0.01% | 1009 |
|
|
2023
Q2 | $2.18K | Hold |
63
| – | – | ﹤0.01% | 741 |
|
|
2023
Q1 | $1.36K | Hold |
63
| – | – | ﹤0.01% | 828 |
|
|
2022
Q4 | $1.35K | Hold |
63
| – | – | ﹤0.01% | 909 |
|
|
2022
Q3 | $2K | Hold |
63
| – | – | ﹤0.01% | 762 |
|
|
2022
Q2 | $1K | Hold |
63
| – | – | ﹤0.01% | 899 |
|
|
2022
Q1 | $2K | Hold |
63
| – | – | ﹤0.01% | 793 |
|
|
2021
Q4 | $2K | Hold |
63
| – | – | ﹤0.01% | 816 |
|
|
2021
Q3 | $3K | Hold |
63
| – | – | ﹤0.01% | 747 |
|
|
2021
Q2 | $3K | Hold |
63
| – | – | ﹤0.01% | 742 |
|
|
2021
Q1 | $3K | Hold |
63
| – | – | ﹤0.01% | 732 |
|
|
2020
Q4 | $2K | Hold |
63
| – | – | ﹤0.01% | 773 |
|
|
2020
Q3 | $1K | Hold |
63
| – | – | ﹤0.01% | 818 |
|
|
2020
Q2 | $2K | Hold |
63
| – | – | ﹤0.01% | 685 |
|
|
2020
Q1 | $1K | Hold |
63
| – | – | ﹤0.01% | 812 |
|
|
2019
Q4 | $1K | Hold |
63
| – | – | ﹤0.01% | 545 |
|
|
2019
Q3 | $2K | Hold |
63
| – | – | ﹤0.01% | 502 |
|
|
2019
Q2 | $3K | Hold |
63
| – | – | ﹤0.01% | 437 |
|
|
2019
Q1 | $9K | Buy |
+63
| New | +$9K | 0.01% | 346 |
|